 |
|
T-Cell Receptor and Immunoglobulin Gene Rearrangements in Diagnosing Skin Disease
Gary S. Wood, MD
Arch Dermatol. 2001;137:1503-1506.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
During the past few decades, there have been major advances in our understanding of the human immune system and its associated lymphoproliferative disorders, including those involving the skin. These advances have been facilitated by the development of new genomic technologies that have led not only to more accurate classification and diagnosis of these diseases but also to fresh insights into their pathogenesis and improved means of staging disease, monitoring response to therapy, and detecting early relapse. Rather than exhaustively summarizing this field, the purpose of this review is to provide an overview of key advances, emphasizing their current and future relevance to general dermatologists. Most of the issues raised in this article are discussed and referenced in greater detail in a recent comprehensive textbook chapter.1
RELEVANT GENOMIC TECHNOLOGIES AND THE CONCEPT OF CLONALITY
The most important advance in the molecular immunological features of lymphomas has been the recognition that each normal T and B . . . [Full Text of this Article]
ADVANCES IN PATHOGENESIS
ADVANCES IN CLASSIFICATION
ADVANCES IN DIAGNOSIS
ADVANCES IN STAGING AND MONITORING
THE FUTURE
RELEVANCE TO THE GENERAL DERMATOLOGIST
From the Department of Medicine (Dermatology), University of Wisconsin, and the Middleton Veterans Affairs Medical Center, Madison.
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(11):1541.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Molecular Diagnosis of Cutaneous Diseases
Sra et al.
Arch Dermatol 2005;141:225-241.
ABSTRACT
| FULL TEXT
|
